Cost-utility of cytisine for smoking cessation over and above behavioural support in people with new...
Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial
About this item
Full title
Author / Creator
Li, Jinshuo , Parrott, Steve , Keding, Ada , Dogar, Omara , Gabe, Rhian , Marshall, Anna-Marie , Huque, Rumana , Barua, Deepa , Fatima, Razia , Khan, Amina , Zahid, Raana , Mansoor, Sonia , Kotz, Daniel , Boeckmann, Melanie , Elsey, Helen , Kralikova, Eva , Readshaw, Anne , Sheikh, Aziz and Siddiqi, Kamran
Publisher
London: British Medical Journal Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
London: British Medical Journal Publishing Group
Subjects
More information
Scope and Contents
Contents
ObjectivesTo assess the cost-effectiveness of cytisine over and above brief behavioural support (BS) for smoking cessation among patients who are newly diagnosed with pulmonary tuberculosis (TB) in low-income and middle-income countries.DesignAn incremental cost-utility analysis was undertaken alongside a 12-month, double-blind, two-arm, individual...
Alternative Titles
Full title
Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_26aadd799ab64dc2bf4f4e2fa07d91ca
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_26aadd799ab64dc2bf4f4e2fa07d91ca
Other Identifiers
ISSN
2044-6055
E-ISSN
2044-6055
DOI
10.1136/bmjopen-2021-049644
